Incyte INCY6.87%increase; up pointing triangle has agreed to buy Vega Therapeutics for up to $2 billion in a deal that expands the biopharmaceutical company’s hematology portfolio into bleeding ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Incyte is upgraded to Buy as pipeline progress and improved EPS estimates offset Jakafi concentration risk. frontMIND Phase 3 data for Monjuvi in first-line DLBCL is promising, supporting potential ...
For severe cases of the bleeding disorder von Willebrand disease, patients must make frequent visits to treatment centers for infusions of the key clotting protein that they lack. Incyte is putting up ...
- Cohort 1 results presented at ENDO 2026 demonstrate meaningful reductions in total heterotopic ossification (HO) lesion volume, new HO lesions and flare activity in adolescents and adults with FOP - ...
Good morning, everyone. Thank you for joining us. It's my pleasure to introduce the Incyte management team. With me, I have Bill Meury, CEO; and Pablo Cagnoni, President and Global Head of R&D. To ...
Threat actors have been using short-form videos on TikTok and Instagram Reels to push the Vidar infostealer, disguising the attacks as tutorials for unlocking premium software for free. New analysis ...
In its largest acquisition to date, Incyte Inc. snagged rights to phase III-stage VGA-039, a monoclonal antibody the firm said could offer a new standard of care in von Willebrand disease (VWD), in a ...
Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. Designed for personal research, portfolio monitoring, and AI-assisted investment ...
Hosted on MSN
Why Incyte (INCY) stock is up today
Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 3.8% in the morning session after several analyst firms raised their price targets following its acquisition of Vega ...
Hosted on MSN
Incyte outlines 10–13% revenue growth for 2026 amid robust pipeline expansion and new product launches
Meury reiterated, "we have set full year '26 revenue guidance of $4.77 billion to $4.94 billion, representing a 10% to 13% increase from prior year," including net revenue expectations for Jakafi of ...
Lauren (Hansen) Holznienkemper is a lead editor for the small business vertical at Forbes Advisor, specializing in HR, payroll and recruiting solutions for small businesses. Using research and writing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results